FRLN

Freeline Therapeutics Holdings plc FRLN

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode FRLN ALLK SER ANPC LMNL MRNS ANGN LSB VINC ELEV
6M 73.07 % -68.66 % -57.04 % 23.56 % 24.63 % -60.43 % 23.21 % -51.02 % -76.36 % -39.91 %
YTD 1.56 % -73.46 % -52.16 % -1.83 % 157.58 % 3.00 % 14.69 % -82.63 % -99.72 % -38.67 %
1Y 3.02 % -71.63 % -53.35 % -27.27 % 67.32 % -76.29 % -10.71 % -78.38 % -99.65 % -54.38 %
3Y -96.77 % -88.29 % -87.58 % -96.85 % -85.17 % -70.11 % -94.12 % -99.37 % -99.94 % -70.80 %
5Y -97.60 % -99.55 % -95.88 % -98.09 % -99.77 % -58.96 % -94.12 % -99.34 % -100.00 % -96.81 %
10Y -97.60 % -98.95 % -97.48 % -98.09 % -99.91 % -94.72 % -94.12 % -99.34 % -99.99 % -96.81 %
From the beginning -97.60 % -98.95 % -97.48 % -98.09 % -99.47 % -93.13 % -94.12 % -99.34 % -99.99 % -96.81 %

Dividend